Filing Flows › Geron (GERN) › Q2 2026 › vs Q1 2026
Geron (GERN) Q2 2026 vs Q1 2026 (quarter over quarter)
Geron's revenue rose $5.6M (+11%) from $51.8M in Q1 2026 to $57.5M in Q2 2026. The biggest changes: Product revenue, net +$5.7M (+11%); Royalties −$59K (-89%).
Geron, Q2 2026: revenue $57.5M (+17% year over year), operating margin -21.7%, net loss $16.7M, operating cash flow −$15.8M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $57.5M | $51.8M | $5.7M | +11% |
| Royalties | $7K | $66K | −$59K | -89% |
| Revenue | $57.5M | $51.8M | $5.6M | +11% |
| Net loss | $16.7M | $3.6M | $13.0M | +358% |
| Costs & expenses | $74.2M | $55.5M | $18.7M | +34% |
| Operating costs | $70.0M | $51.7M | $18.3M | +35% |
| Interest & other, net | $4.2M | $3.8M | $384K | +10% |
| Research & development | $22.0M | $15.0M | $7.1M | +47% |
| SG&A | $38.9M | $35.4M | $3.4M | +10% |
| Other operating costs | $9.1M | $1.3M | $7.8M | +600% |
| Operating cash sources | $20.9M | $68.0M | −$47.0M | -69% |
| Depreciation & amortization | $136K | $134K | $2K | +1% |
| Share-based compensation | $4.9M | $4.9M | $36K | +0.7% |
| Cash used in operations | $15.8M | $62.9M | −$47.1M | -75% |
| Net loss absorbed | $16.7M | $3.6M | $13.0M | +358% |
| Working capital & other | $4.2M | $64.3M | −$60.1M | -93% |
Questions
How much did Geron's revenue grow quarter over quarter in Q2 2026?
Geron's revenue rose $5.6M (+11%) from $51.8M in Q1 2026 to $57.5M in Q2 2026.
What drove Geron's revenue change in Q2 2026?
Product revenue, net +$5.7M (+11%); Royalties −$59K (-89%).